Skip to main content
EXXUA 72.6 mg/1 tablet, extended release by Aytu Therapeutics, LLC
EXXUA, 72.6 mg/1, tablet, extended release Available on prescription only. Listed by Aytu Therapeutics, LLC.
Prescription only

EXXUA

gepirone

Listed by Aytu Therapeutics, LLC

Strength
72.6 mg/1
Form
Tablet, Extended Release
Route
Oral

What it contains

  • Gepirone Hydrochloride 72.6 mg/1

FDA record

Dosage form Tablet, Extended Release
Route Oral
Approval route NDA — original brand approval
NDC code 23594-153
FDA application NDA021164
RxNorm concept 2672372
Package sizes listed 1
Marketed since October 2025

Other products containing Gepirone

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EXXUA

gepirone

Strength
54.5 mg/1
Form
Tablet, Extended Release
Rx only

Aytu Therapeutics, LLC

Not stocked by us — reference only

EXXUA

gepirone

Strength
18.2 mg/1
Form
Tablet, Extended Release
Rx only

Aytu Therapeutics, LLC

Not stocked by us — reference only

EXXUA

gepirone

Strength
36.3 mg/1
Form
Tablet, Extended Release
Rx only

Aytu Therapeutics, LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.